14Dec 2017

KAPOSIS SARCOMA IN PATIENT UNDERGOING DIALYSIS AFTER TREATMENT OF LUPUS NEPHRITIS: A CASE REPORT.

  • Doctor, Nephrology department, Moulay Ismail Military Hospital, Meknes, Morocco.
  • Professor, Nephrology department, Moulay Ismail Military Hospital, Meknes, Morocco.
Crossref Cited-by Linking logo
  • Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

Kaposi?s Sarcoma (KS) is a low-grade vascular tumor that derived from lymphatic endothelial cells infected with type 8 of human herpes virus (HHV8) also known as Kaposi Sarcoma associated herpesvirus (KSHV). Iatrogenic form of KS is most often detected in patients after kidney transplantation which reflects the higher frequency in this population. KSis most notable for its cutaneous involvement, characterized by dermal purplish, reddish blue, or dark black macules, plaques, and nodules. Lymph node enlargement and visceral localization are other clinical manifestation of KS. Visceral involvement occurs in 25 to 30 percent of patients with kidney transplants and in 50 percent of those with liver or heart transplants. We present a 46-year-old man undergoing dialysis due to lupus nephritis, with multiple lymph nodes who had biopsy-proven KS.

  1. Pietti WW. The incidence of secong malignancies in subsets of Kaposi?s sarcoma. J Am Acad Dermatol 1987; 16: 855-61
  2. Penn I. The changing patterns of posttransplant malignancies. Transplant proc 1991; 23: 1101-3
  3. Beral V. Epidemiology of Kaposi?s sarcoma. In: Franks LM, eds: Cancer surveys. New York: Cold Spring Harber Lab Press, 1991; 5
  4. Hengge UR, Ruzicka T, Tyring SK, et al. Update on Kaposi?s sarcoma and other HHV8 associated diseases. Part 1: epidemiology, environmental predispositions, clinical manifestations, and therapy. Lancet Infect Dis 2002 ; 2 : 281-92
  5. Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Engl J Med. 2003; 348(17): 1681 ? 1691
  6. Einollahi B. Unusual site of Kaposi sarcoma after kidney transplantation. Iranian Journal of Kidney Diseases. 2012; 6(3): 164 ? 165
  7. Cai Q, Verma SC, Lu J, Robertson ES. Robertson molecular biology of Kaposi?s sarcoma-associated herpesvirus and related oncogenesis. Adv Virus Res 2010 ; 78 : 87-142
  8. Costa Ferreira P, Miguel Pereira J, Oliveira I, Pinho C, Cardoso A, Reis J, et al. Unusual Kaposi?s sarcoma in a renal transplant recipient. Nephrol Dial Transplant. 2005; 20(12): 2830 ? 2831
  9. Charfi S, Krichen-Makni S, Yaich S, Makni H, Khabir A, Amouri A, et al. Successful treatment of post-renal transplant gastric and pulmonary Kaposi?s sarcoma with conversion to rapamycin treatment. Saudi J Kidney Dis Transpl. 2007; 18(4): 617 ? 620
  10. Campistol JM, Schena FP. Kaposi?s sarcoma in renal transplant recipients-- the impact of proliferation signal inhibitors. Nephrol Dial 2007; 22(Suppl 1): i17 ? i22

[Mohamed Reda El Farouki and Mohamed Hassani. (2017); KAPOSIS SARCOMA IN PATIENT UNDERGOING DIALYSIS AFTER TREATMENT OF LUPUS NEPHRITIS: A CASE REPORT. Int. J. of Adv. Res. 5 (Dec). 653-656] (ISSN 2320-5407). www.journalijar.com

Mohamed Reda El Farouki
Nephrology Department, Moulay Ismail Military Hospital, Meknes, Morocco

DOI:

Article DOI: 10.21474/IJAR01/6004      
DOI URL: http://dx.doi.org/10.21474/IJAR01/6004

Download Full Paper

Download PDF No. of Downloads: 3 | No. of Views: 69